Reticulohistiocytosis - 09/08/11
Doi : 10.1016/j.det.2007.06.015
Flávio Barbosa Luz, MD, PhD a, Patricia Shu Kurizky, MD b, Marcia Ramos-e-Silva, MD, PhD c, ⁎ 
a General Policlinics of Rio de Janeiro/Carlos Chagas Medical Post-Graduation Institute, Rua Desembargador Izidro 28/1001, 20521-160 Rio de Janeiro, Brazil
b Post-Graduation Course in Dermatology, Sector of Dermatology, Universidade Federal Fluminense, Rua Henrique Cordeiro 120/603 Bl. 01, 22631-450 Rio de Janeiro, Niterói, Brazil
c Sector of Dermatology and Post-Graduation Course, University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rua Dona Mariana 143/C-32, 22280-020 Rio de Janeiro, Brazil
Corresponding author.Abstract |
Reticulohistiocytoses consist of a rare group of diseases caused by CD68+ macrophage proliferation. Several advances have been achieved in relation to the receptors involved in these diseases. This knowledge will clarify the physiopathologic mechanisms of the reticulohistiocytoses and direct better therapeutic approaches for patients.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Elsevier Inc. Tous droits réservés.
Vol 25 - N° 4
P. 625-632 - octobre 2007 Retour au numéro
Article précédent
- Contact Dermatitis
- Nanna Fyhrquist-Vanni, Harri Alenius, Antti Lauerma
- UV Light and Its Interaction with Cutaneous Receptors
- Hagit Matz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?